Literature DB >> 17998970

Now we know the drug of first choice--or do we?

Jacqueline A French.   

Abstract

Year:  2007        PMID： 17998970      PMCID： PMC2043139          DOI： 10.1111/j.1535-7511.2007.00197.x

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  8 in total

1.  Exacerbation of juvenile myoclonic epilepsy with lamotrigine.

Authors:  A Biraben; H Allain; J M Scarabin; S Schück; G Edan
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

Review 2.  Therapeutic safety monitoring: what to look for and when to look for it.

Authors:  C L Harden
Journal:  Epilepsia       Date:  2000       Impact factor: 5.864

3.  Lamotrigine associated with exacerbation or de novo myoclonus in idiopathic generalized epilepsies.

Authors:  A Crespel; P Genton; M Berramdane; P Coubes; C Monicard; M Baldy-Moulinier; P Gelisse
Journal:  Neurology       Date:  2005-09-13       Impact factor: 9.910

Review 4.  Felbamate: consensus of current clinical experience.

Authors:  John M Pellock; Edward Faught; Ilo E Leppik; Shlomo Shinnar; Mary L Zupanc
Journal:  Epilepsy Res       Date:  2006-08-04       Impact factor: 3.045

5.  Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures.

Authors:  R H Mattson; J A Cramer; J F Collins; D B Smith; A V Delgado-Escueta; T R Browne; P D Williamson; D M Treiman; J O McNamara; C B McCutchen
Journal:  N Engl J Med       Date:  1985-07-18       Impact factor: 91.245

6.  A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group.

Authors:  R H Mattson; J A Cramer; J F Collins
Journal:  N Engl J Med       Date:  1992-09-10       Impact factor: 91.245

7.  The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial.

Authors:  Anthony G Marson; Asya M Al-Kharusi; Muna Alwaidh; Richard Appleton; Gus A Baker; David W Chadwick; Celia Cramp; Oliver C Cockerell; Paul N Cooper; Julie Doughty; Barbara Eaton; Carrol Gamble; Peter J Goulding; Stephen J L Howell; Adrian Hughes; Margaret Jackson; Ann Jacoby; Mark Kellett; Geoffrey R Lawson; John Paul Leach; Paola Nicolaides; Richard Roberts; Phil Shackley; Jing Shen; David F Smith; Philip E M Smith; Catrin Tudur Smith; Alessandra Vanoli; Paula R Williamson
Journal:  Lancet       Date:  2007-03-24       Impact factor: 79.321

8.  The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial.

Authors:  Anthony G Marson; Asya M Al-Kharusi; Muna Alwaidh; Richard Appleton; Gus A Baker; David W Chadwick; Celia Cramp; Oliver C Cockerell; Paul N Cooper; Julie Doughty; Barbara Eaton; Carrol Gamble; Peter J Goulding; Stephen J L Howell; Adrian Hughes; Margaret Jackson; Ann Jacoby; Mark Kellett; Geoffrey R Lawson; John Paul Leach; Paola Nicolaides; Richard Roberts; Phil Shackley; Jing Shen; David F Smith; Philip E M Smith; Catrin Tudur Smith; Alessandra Vanoli; Paula R Williamson
Journal:  Lancet       Date:  2007-03-24       Impact factor: 79.321
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.